IC
AYLA

Ikarian Capital’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Ikarian Capital’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-697,316
Closed -$759K – 176
2022
Q2 		$759K Sell
697,316
-11,067
-2% -$25.3K 0.14% 88
2022
Q1 		$2.82M Buy
708,383
+39,112
+6% +$203K 0.37% 56
2021
Q4 		$5.7M Buy
669,271
+130,332
+24% +$1.29M 0.85% 30
2021
Q3 		$6.11M Buy
+538,939
New +$6.47M 0.43% 55

Other funds holding AYLA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital's AYLA Position: Q3 2022 in Review

Ikarian Capital sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q3 2022, closing a stake of 697,316 shares — an estimated $759K sold.

Ikarian Capital first reported a position in AYLA in Q3 2021 and held it in 4 quarters. The position peaked at $6.11M in Q3 2021. 14 funds tracked by Wall St. Rank hold AYLA as of Q3 2022.

  • Ikarian Capital reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 697,316 Ayala Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $759K.
  • Ikarian Capital first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Ikarian Capital's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $6.11M in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.